Drug Shortage Report for TEVA-BETAMETHASONE/ CALCIPOTRIOL
| Report ID | 266193 |
| Drug Identification Number | 02427419 |
| Brand name | TEVA-BETAMETHASONE/ CALCIPOTRIOL |
| Common or Proper name | BETAMET DIP/CALCIPOT OINT |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BETAMETHASONE CALCIPOTRIOL |
| Strength(s) | 0.5MG 50MCG |
| Dosage form(s) | OINTMENT |
| Route of administration | TOPICAL |
| Packaging size | 120g |
| ATC code | D07XC |
| ATC description | CORTICOSTEROIDS, OTHER COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-08-27 |
| Estimated end date | 2025-09-20 |
| Actual end date | 2025-09-08 |
| Shortage status | Resolved |
| Updated date | 2025-09-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-09-11 | French | Compare |
| v3 | 2025-09-11 | English | Compare |
| v2 | 2025-08-29 | French | Compare |
| v1 | 2025-08-29 | English | Compare |
Showing 1 to 4 of 4